BRPI1013835B8 - método para produção de material biologicamente ativo de nanopartícula e/ou micropartícula, composição compreendendo referido material, composição farmacêutica, uso da mesma, e, método para produção de uma composição farmacêutica, de um produto veterinário e de um produto agrícola - Google Patents

método para produção de material biologicamente ativo de nanopartícula e/ou micropartícula, composição compreendendo referido material, composição farmacêutica, uso da mesma, e, método para produção de uma composição farmacêutica, de um produto veterinário e de um produto agrícola

Info

Publication number: BRPI1013835B8
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; producing; biologically active; nanoparticle; microparticle
Prior art date: 2009-04-24

Application number

BRPI1013835A

Other languages

English (en)

Portuguese (pt)

Inventor

Russell Adrian

Dodd Aaron

Meiser Felix

Norret Marck

H Bosch William

Original Assignee

Iceutica Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-24

Filing date

2010-04-23

Publication date

2021-05-25

2009-04-24 Priority claimed from AU2009901747A external-priority patent/AU2009901747A0/en

2010-04-23 Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd

2010-04-23 Priority claimed from PCT/AU2010/000467 external-priority patent/WO2010121323A1/en

2021-04-20 Publication of BRPI1013835B1 publication Critical patent/BRPI1013835B1/pt

2021-05-25 Publication of BRPI1013835B8 publication Critical patent/BRPI1013835B8/pt

Links

Classifications

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI1013835A 2009-04-24 2010-04-23 método para produção de material biologicamente ativo de nanopartícula e/ou micropartícula, composição compreendendo referido material, composição farmacêutica, uso da mesma, e, método para produção de uma composição farmacêutica, de um produto veterinário e de um produto agrícola BRPI1013835B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US17230009P	2009-04-24	2009-04-24
AU2009901747		2009-04-24
AU2009901747A AU2009901747A0 (en)		2009-04-24	Method for the Production of Commercial Nanoparticle and Microparticle Powders
US61/172,300		2009-04-24
PCT/AU2010/000467 WO2010121323A1 (en)	2009-04-24	2010-04-23	Method for the production of commercial nanoparticle and microparticle powders

Publications (2)

Publication Number	Publication Date
BRPI1013835B1 BRPI1013835B1 (pt)	2021-04-20
BRPI1013835B8 true BRPI1013835B8 (pt)	2021-05-25

Family

ID=65905676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1013835A BRPI1013835B8 (pt)	2009-04-24	2010-04-23	método para produção de material biologicamente ativo de nanopartícula e/ou micropartícula, composição compreendendo referido material, composição farmacêutica, uso da mesma, e, método para produção de uma composição farmacêutica, de um produto veterinário e de um produto agrícola

Country Status (2)

Country	Link
JP (1)	JP2019048854A (ja)
BR (1)	BRPI1013835B8 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114717677B (zh) *	2022-03-31	2023-09-26	广东粤港澳大湾区国家纳米科技创新研究院	纳米金无纺布及其制备方法和应用
CN115105532A (zh) *	2022-05-31	2022-09-27	复旦大学附属中山医院	一种人胆汁冻干粉的制备方法
CN116004451B (zh) *	2022-12-08	2023-07-18	贵州大学	一种复合颗粒型微生物菌剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4117811B2 (ja) *	1997-04-22	2008-07-16	日本化薬株式会社	フルタミド製剤及びその製法
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
JP2004099442A (ja) *	2002-09-04	2004-04-02	Nisshin Pharma Inc	難溶性薬物含有製剤およびその製造方法
EP1973523A2 (en) *	2005-12-15	2008-10-01	Acusphere, Inc.	Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
EA201171282A1 (ru) *	2009-04-24	2012-05-30	Айсьютика Пти Лтд.	Способ производства коммерческих порошков, содержащих нано- и микрочастицы

2010
- 2010-04-23 BR BRPI1013835A patent/BRPI1013835B8/pt not_active IP Right Cessation
2018
- 2018-11-19 JP JP2018216547A patent/JP2019048854A/ja active Pending

Also Published As

Publication number	Publication date
JP2019048854A (ja)	2019-03-28
BRPI1013835B1 (pt)	2021-04-20

Similar Documents

Publication	Publication Date	Title
BRPI1014276B8 (pt)	2021-05-25	produção de nanopartículas encapsuladas em escala comercial
MY179872A (en)	2020-11-18	Method for the production of commercial nanoparticle and microparticle powders
MY159098A (en)	2016-12-15	Production of encapsulated nanoparticles at high volume fractions
BRPI1014275B8 (pt)	2021-05-25	composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos
BRPI1014278B8 (pt)	2021-05-25	método para produzir uma forma de dosagem compreendendo metaxolona, forma de dosagem, composição farmacêutica compreendendo a referida forma de dosagem e uso da mesma
PH12015500301B1 (en)	2015-12-07	A novel formulation of diclofenac
PH12016500746A1 (en)	2018-01-29	A novel formulation of meloxicam
TN2011000536A1 (en)	2013-05-24	A novel formulation of naproxen
BRPI1013835B8 (pt)	2021-05-25	método para produção de material biologicamente ativo de nanopartícula e/ou micropartícula, composição compreendendo referido material, composição farmacêutica, uso da mesma, e, método para produção de uma composição farmacêutica, de um produto veterinário e de um produto agrícola
PH12015501811A1 (en)	2019-03-25	Production of encapsulated nanoparticles at high volume fractions
NZ710321A (en)	2017-04-28	Production of encapsulated nanoparticles at high volume fractions
TH135892A (th)	2014-08-18	สูตรตำรับใหม่ของเมลอกซีแคม
TH125551A (th)	2013-07-24	การผลิตของอนุภาคนาโนที่ถูกกักเก็บที่ขนาดทางการค้า
TH135130B (th)	2014-07-08	วิธีการสำหรับการปรับปรุงรายละเอียดการละลายของวัสดุออกฤทธิ์ทางชีวภาพ
TH140025A (th)	2015-02-27	วิธีการสำหรับการผลิตผงอนุภาคนาโนและอนุภาคไมโครทางการค้า
TH135892B (th)	2014-08-18	สูตรตำรับใหม่ของเมลอกซีแคม
TH125552A (th)	2013-07-24	การผลิตของอนุภาคนาโนที่ถูกกักเก็บที่สัดส่วนเชิงปริมาตรสูง
TH125551B (th)	2013-07-24	การผลิตของอนุภาคนาโนที่ถูกกักเก็บที่ขนาดทางการค้า
TH140026A (th)	2015-02-27	สูตรตำรับใหม่ของอินโดเมธาซิน

Legal Events

Date	Code	Title	Description
2019-08-06	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-08-06	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-05-05	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-05-12	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-09-15	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-03-02	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-04-20	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2022-02-15	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 12A ANUIDADE.
2022-05-31	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2667 DE 15-02-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.